Viewing Study NCT01793168

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 5:34 PM
Ignite Modification Date: 2026-02-11 @ 3:55 AM
Study NCT ID: NCT01793168
Status: RECRUITING
Last Update Posted: 2025-05-29
First Post: 2013-02-13
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford
Sponsor: Sanford Health
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Organization Data

Organization:
Class: OTHER
Study ID: 03-10-014
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators

Collaborators

Name Class View
None OTHER View
None UNKNOWN View
None OTHER View
None UNKNOWN View
None UNKNOWN View
None UNKNOWN View
None UNKNOWN View
None UNKNOWN View
None UNKNOWN View
None UNKNOWN View
None UNKNOWN View
None OTHER View
None UNKNOWN View
None UNKNOWN View
None OTHER View
None UNKNOWN View
None UNKNOWN View
None UNKNOWN View
None UNKNOWN View
None UNKNOWN View
None UNKNOWN View
None UNKNOWN View
None UNKNOWN View
None UNKNOWN View
None UNKNOWN View
None UNKNOWN View
None UNKNOWN View
None UNKNOWN View
None UNKNOWN View
None UNKNOWN View
None OTHER View
None UNKNOWN View
None UNKNOWN View
None UNKNOWN View
None UNKNOWN View
None UNKNOWN View
None OTHER View
None UNKNOWN View
None UNKNOWN View
None UNKNOWN View
None UNKNOWN View
None UNKNOWN View
None UNKNOWN View
None UNKNOWN View
None UNKNOWN View
None UNKNOWN View
None UNKNOWN View
None OTHER View
None OTHER View
None UNKNOWN View
None UNKNOWN View
None UNKNOWN View
None UNKNOWN View
None UNKNOWN View
None UNKNOWN View
None UNKNOWN View
None UNKNOWN View
None UNKNOWN View
None UNKNOWN View
None UNKNOWN View
None UNKNOWN View
None UNKNOWN View
None UNKNOWN View
None UNKNOWN View
None UNKNOWN View
None UNKNOWN View
None UNKNOWN View
None UNKNOWN View
None UNKNOWN View
None UNKNOWN View
None UNKNOWN View
None UNKNOWN View
None UNKNOWN View
None UNKNOWN View
None UNKNOWN View
None UNKNOWN View
None UNKNOWN View
None UNKNOWN View
None UNKNOWN View
None UNKNOWN View
None UNKNOWN View
None UNKNOWN View
None UNKNOWN View
None UNKNOWN View
None UNKNOWN View
None UNKNOWN View
None UNKNOWN View
None UNKNOWN View
None UNKNOWN View
None UNKNOWN View
None UNKNOWN View
None UNKNOWN View
None UNKNOWN View
None UNKNOWN View
None UNKNOWN View
None UNKNOWN View
None UNKNOWN View
None UNKNOWN View
None UNKNOWN View
None UNKNOWN View
None UNKNOWN View
None UNKNOWN View
None UNKNOWN View
None UNKNOWN View
None UNKNOWN View
None UNKNOWN View
None UNKNOWN View
None UNKNOWN View
None UNKNOWN View
None UNKNOWN View
None UNKNOWN View
None UNKNOWN View
None UNKNOWN View
None UNKNOWN View
None UNKNOWN View
None UNKNOWN View
None UNKNOWN View
None UNKNOWN View
None UNKNOWN View
None UNKNOWN View
None UNKNOWN View
None UNKNOWN View